Showing 1 - 10 results of 54 for search '', 查詢時間: 0.03s Refine Results
  1. 1

    DOST ends Ivermectin clinical trials 由 Nazario, Dhel

    發表在 Manila Bulletin (2022)
    Article

    DOST ends Ivermectin clinical trials
  2. 2

    Clearances for PH Ivermectin clinical trial expected to be released this month - DOST 由 Luci, Charissa M.

    發表在 Manila Bulletin (2022)
    Article

    Clearances for PH Ivermectin clinical trial expected to be released this month - DOST
  3. 3

    DOST shells out P22 m for ivermectin clinical trials 由 Ronda, Rainier Allan

    發表在 Philippine Star (2021)
    Article

    DOST shells out P22 m for ivermectin clinical trials
  4. 4

    P22-M clinical trials for Ivermectin as COVID-19 treatment begin in June 由 Luci, Charissa M.

    發表在 Manila Bulletin (2021)
    Article

    P22-M clinical trials for Ivermectin as COVID-19 treatment begin in June
  5. 5

    FDA allows 2 more hospitals to use Ivermectin 由 Crisostomo, Sheila

    發表在 Philippine Star (2021)
    Article

    FDA allows 2 more hospitals to use Ivermectin
  6. 6

    Experts question compassionate use approval for Ivermectin 由 Punay, Eduardo

    發表在 Philippine Star (2021)
    Article

    Experts question compassionate use approval for Ivermectin
  7. 7

    Duterte wants study on Ivermectin completed soon 由 Geducos, Argyll Cyrus B.

    發表在 Manila Bulletin (2021)
    Article

    Duterte wants study on Ivermectin completed soon
  8. 8

    Drug developers, public to benefit from PH Ivermectin clinical trials - DOST 由 Luci, Charissa M.

    發表在 Manila Bulletin (2021)
    Article

    Drug developers, public to benefit from PH Ivermectin clinical trials - DOST
  9. 9

    DOH, FDA tell Go Use of human-grade Ivermectin not illegal 由 Casayuran, Mario B.

    發表在 Manila Bulletin (2021)
    Article

    DOH, FDA tell Go Use of human-grade Ivermectin not illegal
  10. 10

    Ivermectin. IN Editorial [column] boon or bane?

    發表在 Philippine Star (2021)
    Article

    Ivermectin. IN Editorial [column] boon or bane?

檢索工具: